IN2013DE02956A - - Google Patents

Info

Publication number
IN2013DE02956A
IN2013DE02956A IN2956DE2013A IN2013DE02956A IN 2013DE02956 A IN2013DE02956 A IN 2013DE02956A IN 2956DE2013 A IN2956DE2013 A IN 2956DE2013A IN 2013DE02956 A IN2013DE02956 A IN 2013DE02956A
Authority
IN
India
Prior art keywords
osletamivir
imidazothiazolone
amidoalkylation
ramberg
tamiflu
Prior art date
Application number
Other languages
English (en)
Inventor
Prataprao Chavan Subhash
Narsing Chavan Prakash
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Priority to EP14811991.0A priority Critical patent/EP3052473B1/en
Priority to IN2956DE2013 priority patent/IN2013DE02956A/en
Priority to US15/026,376 priority patent/US9522922B2/en
Priority to PCT/IN2014/000645 priority patent/WO2015049700A1/en
Priority to JP2016520012A priority patent/JP6474392B2/ja
Publication of IN2013DE02956A publication Critical patent/IN2013DE02956A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/36—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2956DE2013 2013-10-04 2014-10-07 IN2013DE02956A (sl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP14811991.0A EP3052473B1 (en) 2013-10-04 2014-10-07 A process for the preparation of intermediate for the preparation of oseltamivir phosphate
IN2956DE2013 IN2013DE02956A (sl) 2013-10-04 2014-10-07
US15/026,376 US9522922B2 (en) 2013-10-04 2014-10-07 Process for the preparation of intermediate for the preparation of oseltamivir phosphate
PCT/IN2014/000645 WO2015049700A1 (en) 2013-10-04 2014-10-07 A process for the preparation of intermediate for the preparation of oseltamivir phosphate
JP2016520012A JP6474392B2 (ja) 2013-10-04 2014-10-07 リン酸オセルタミビル調製用中間体の調製方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2956DE2013 IN2013DE02956A (sl) 2013-10-04 2014-10-07

Publications (1)

Publication Number Publication Date
IN2013DE02956A true IN2013DE02956A (sl) 2015-04-10

Family

ID=52023584

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2956DE2013 IN2013DE02956A (sl) 2013-10-04 2014-10-07

Country Status (5)

Country Link
US (1) US9522922B2 (sl)
EP (1) EP3052473B1 (sl)
JP (1) JP6474392B2 (sl)
IN (1) IN2013DE02956A (sl)
WO (1) WO2015049700A1 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018189108A1 (en) 2017-04-12 2018-10-18 Dsm Ip Assets B.V. A process for preparation of an imidazothiazolone compound
CN109890790B (zh) * 2017-06-20 2020-04-21 广东东阳光药业有限公司 一种奥司他韦及其异构体的制备方法
US10385010B1 (en) * 2018-03-28 2019-08-20 Georgia State University Research Foundation, Inc. Expedient synthesis of oseltamivir and related compounds via direct olefin diazidation-diamidation reaction
CN111349059B (zh) * 2018-12-20 2023-03-31 中国科学院上海药物研究所 一类手性环氧化合物的制备方法
CN113307744A (zh) * 2021-05-29 2021-08-27 弘健制药(上海)有限公司 一种磷酸奥司他韦的制备方法
CN114478290A (zh) * 2022-01-24 2022-05-13 广东中润药物研发有限公司 奥司他韦中间体的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486328B1 (en) * 2000-10-12 2002-11-26 Council Of Scientific And Industrial Research Substituted 2-[-6-benzyl-5-oxo-3-phenyl-(3s,7s, 7aR)-perhydroimidazol[1,5-c][1,3]thiazol-7yl] compounds
WO2007099843A1 (ja) 2006-02-23 2007-09-07 The University Of Tokyo α，β-不飽和シクロヘキサノン誘導体及びその製造方法、並びにその中間体の製造方法
JP2008081489A (ja) 2006-08-31 2008-04-10 Univ Of Tokyo 環状ウレタン化合物及びその製造方法

Also Published As

Publication number Publication date
EP3052473A1 (en) 2016-08-10
US9522922B2 (en) 2016-12-20
EP3052473B1 (en) 2018-01-17
WO2015049700A1 (en) 2015-04-09
JP2016537315A (ja) 2016-12-01
JP6474392B2 (ja) 2019-02-27
US20160222029A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
MX2017015133A (es) Procesos para producir brivaracetam.
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
IN2013DE02956A (sl)
PH12018501094A1 (en) Process for the preparation of an apoptosis-inducing agent
SG10201903962PA (en) Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
MX2017008280A (es) Proceso para elaborar cenicriviroc y analogos relacionados.
PH12018550165A1 (en) An improved process for the preparation of butorphanol tartrate
NZ720106A (en) A process for the preparation of regadenoson
MX2017014662A (es) Proceso nuevo para la eterificacion de las bis-resorcinil triazinas.
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
IN2014CH00290A (sl)
WO2014141294A3 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
MX2023009432A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio.
IN2014CH00304A (sl)
IN2013MU01113A (sl)
MX2016015298A (es) Inhibidores de nampt y metodos.
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
IN2013MU00916A (sl)
MX2016011534A (es) Un proceso mejorado para la preparacion de exametazima.
MX2017000318A (es) Derivados del acido abscisico sustituido en 3'.
TW201612142A (en) Process for preparing 3-chloro-2-vinylphenol
MX2019014989A (es) Proceso para la preparacion de (s,s)-secoisolariciresinol diglucosido y (r,r)-secoisolariciresinol diglucosido.
IN2013CH05865A (sl)
MX2018007638A (es) Proceso mejorado para preparar crotonilaminopiridinas.